Introduction
Basal cell nevus syndrome (BCNS or Gorlin syndrome), which is associated with heterozygous germline mutation of patched1 (PTCH1), is characterized by a large body size, skeletal abnormalities, radiation sensitivity, soft tissue sarcoma, basal cell carcinoma and medulloblastoma (Gorlin, 1987) . Medulloblastoma, the most common malignant pediatric brain tumor, is a primitive neuroectodermal tumor that arises in the developing cerebellum. Mutations in the sonic hedgehog (SHH) pathway signaling genes, PTCH1 (10%), smoothened, SMOH (6%) and suppressor-of-fused, SUFU (9%) have been reported to occur in sporadic medulloblastoma (Raffel et al., 1997; Vorechovsky et al., 1997; Wolter et al., 1997; Xie et al., 1997; Reifenberger et al., 1998; Dong et al., 2000; Zurawel et al., 2000a; Taylor et al., 2002) . Mice heterozygous for Ptc1 display several features of Gorlin syndrome and they develop both rhabdomyosarcoma and medulloblastoma (Goodrich et al., 1997) . Previously, we reported that Ptc1 þ /À mice on a C57Bl/6 background exhibit a 14% incidence of medulloblastoma by 10 months of age (Wetmore et al., 2000) . All medulloblastomas examined from Ptc1 þ /À mice expressed Gli1 and the remaining wild-type Ptc1 allele (Wetmore et al., 2000; Zurawel et al., 2000b) . Thus, medulloblastoma formation in Ptc1 þ /À mice occurs as a consequence of haploinsufficiency of Ptc1. Since Ptc1 functions to repress Smo, these results imply that reduced expression of Ptc1 leads to increased pathway signaling and ultimately tumorigenesis.
Hedgehog (Hh) is a secreted protein that is highly conserved from flies to mammals (Ingham and McMahon, 2001 ). The three mammalian Hh family members, Shh, Indian hedgehog (Ihh) and Desert hedgehog (Dhh), are involved in cell growth, proliferation and differentiation (Ingham and McMahon, 2001 ). Shhdeficient mice exhibit embryonic lethality with skeletal abnormalities, defects in neuronal development and small body size (Chiang et al., 1996) . In the cerebellum, Shh is detectable in Purkinje cells as early as embryonic day (E) 17.5 in mice (Lewis et al., 2004) . Ptc1-null mice also show lethality at E 9.5 as a consequence of ectopic activation of Smo (Goodrich et al., 1997) . Binding of Shh to Ptc1 results in derepression of Smo and increased downstream signaling, which results in elevated expression of Gli1 (Ingham and McMahon, 2001 ). The Gli family of zinc-finger transcription factors is composed of three members, Gli1, Gli2 and Gli3 in mice and humans. Targeted disruption of the zinc-finger region together with the adjacent 43 amino acids (Gli1 zfd ) or disruption in the entire Gli1 N-terminus and zinc-finger region by lacZ insertion (Gli1 lZ ) in mice shows no obvious biological effect (Park et al., 2000; Bai et al., 2002) . In contrast, disruption of Gli2 or Gli3 in mice results in severe skeletal and neural defects and embryonic or perinatal lethality (Hui and Joyner, 1993; Mo et al., 1997) . Double mutation of Gli1 and Gli2 causes more severe developmental defects than loss of Gli2 alone (Park et al., 2000; Bai et al., 2002) . These findings suggest that Shh signaling is critical for normal development and that Gli1 and Gli2 have overlapping functions. This hypothesis was confirmed directly by substitution of Gli1 into the Gli2 locus (Bai and Joyner, 2001) .
Increased activity of the Shh pathway is associated with oncogenesis in many cell types. For example, overexpression of either Shh, Gli1, Gli2 or a constitutively active mutant of Smo under the control of a keratin promoter in mice causes basal cell carcinoma (Oro et al., 1997; Grachtchouk et al., 2000 Grachtchouk et al., , 2003 Nilsson et al., 2000; Oro and Higgins, 2003) . Furthermore, in primary rat fibroblasts, overexpression of Gli1 induces morphological transformation in cooperation with the oncoprotein E1A (Ruppert et al., 1991) , suggesting that deregulation of Smo signaling promotes tumorigenesis. Recently, it was shown that ectopic expression of Shh in granule cells in the developing cerebellum of Gli1 lZ mice induced medulloblastoma formation (Weiner et al., 2002) , suggesting that Gli1 is not required for tumorigenesis. However, since Gli family members exhibit functional redundancy and compensation, and mice with targeted deletions in different Gli genes show distinct phenotypes, it is important to investigate the specific role of each family member in a mouse model of spontaneous tumor formation. Here we investigate the contribution of Gli1 to oncogenesis in mice heterozygous for Ptc1. We found that medulloblastoma formation in Ptc1 þ /À mice was dramatically reduced but not completely eliminated in the absence of Gli1. Thus, Gli1 is a crucial contributor to medulloblastoma formation in Ptc1 þ /À mice, but it is likely that Gli2 shares this oncogenic function.
Results

Transcription properties of Gli proteins
As a first step in investigating the oncogenic potential of Gli proteins, we compared their transcriptional activity using a Gli luciferase (Gli-luc) reporter construct that provides a convenient and sensitive marker for transcription activity (Sasaki et al., 1999) . Comparison of the transcriptional activities of Gli family members revealed that Gli1 exhibited the strongest transcriptional activity, Gli2 possessed approximately half the activity of Gli1, whereas Gli3 was not active in this assay. Since Gli1 is localized in the cytoplasm in 293 T and NIH 3T3 cells (Koyabu et al., 2001) , we added a nuclear localization sequence (NLS), derived from SV40 Large T antigen, into the N-terminus of Gli1 and Gli1 mutants. We expected that the NLS fused mutants would have higher transcriptional activity; however, this was not the case ( Figure 1A ). The addition of an NLS was not sufficient to enhance nuclear translocation of Gli1. While the majority of NLS-FLAG (NF)-Gli1 was localized in the cytoplasm (data not shown), it was just as active as wild-type Gli1 in the Gli-luc assay.
Substitution of the transactivation domain in Gli1 with the VP16 transactivation domain (NF-Gli1VP16) resulted in higher transcriptional activity than wildtype Gli1. Mutants lacking the entire Zn-finger motif (amino acids 240-394) (Gli1 zfd240-394 ) did not show any luciferase activity ). The expression level of the Gli protein constructs was confirmed using anti-FLAG and anti-Gli1 C-terminal antibodies (data not shown).
Gli1 and Gli2, but not Gli3 transform cultured fibroblasts
We used a retroviral vector system to examine the transforming activity of Gli family members and Gli1 mutants in NIH 3T3 cells and 208F rat fibroblasts. The Gli constructs that were active in the Gli-luc reporter assay, F-Gli1, NF-Gli1 and NF-Gli1VP16 were all capable of inducing expression of the endogenous Ptc1 and Gli1 genes in NIH 3T3 cells ( Figure 1B ). Gli2 also induced both Gli1 and Ptc1 expression at lower levels than those induced by Gli1, whereas NF-Gli1 zfd240-394 and Gli3 did not activate the endogenous targets. These data confirm the results of the luciferase assay that Gli2 is a weaker transactivator than Gli1 ( Figure 1A ). We found that Shh induces Gli transcriptional activity in 208F cells as determined by the Gli-luc reporter assay (data not shown). We next examined the morphological transformation potential of Gli family members and Gli1 mutants in 208F cells (Miao and Curran, 1994) ( Figure 1C ). Only the constructs capable of causing transactivation (F-Gli1, NF-Gli1, NF-GliVP16 and FGli2) were able to induce morphological transformation ( Figure 1C , b, c, f and g). These results imply that activation of target genes by Gli1 or Gli2 is required for morphological transformation. Gli3 did not induce transformation ( Figure 1C , h), and F-Gli2 exhibited less transforming activity than F-Gli1 ( Figure 1C, g ). Furthermore, NIH3T3 cells expressing F-Gli1 or NFGli1VP16 were able to form colonies in soft agar ( Figure  1D , b and c). Cells expressing F-Gli2 grew in agar, but they formed smaller colonies than those expressing FGli1 or NF-Gli1VP16 and they arose after a longer period of culture ( Figure 1D, d ). Cells expressing F-Gli1 or F-Gli2 grew more readily in soft agar in the presence of Shh than in the absence of Shh, whereas F-Gli3-expressing cells did not form colonies in soft agar even when cultured in the presence of Shh (data not shown). Taken together, these results confirm that Gli1 is the strongest activator among Gli family members and that Gli1 induces cell transformation through its transcription activation function. Although NF-Gli1VP16 is a stronger activator and it induced enhanced cell growth in agar, it is not as efficient as wild-type Gli1 at inducing morphological transformation. This suggests that the activation domain of Gli1 may confer specificity for target genes involved in transformation. Although Gli2 induces morphological transformation, it is less potent than Gli1. Since Gli2 induces expression of endogenous Gli1, transformation may be accomplished through the activation of common target genes either directly or indirectly.
Medulloblastoma incidence in Ptc1
þ /À mice is severely reduced in the absence of Gli1
To examine whether Gli1 contributes to medulloblastoma formation, we crossed Ptc1 þ /À mice on a mixed C57Bl/6 and 129Sv background (Wetmore et al., 2000) with Gli1 zfd mice (Park et al., 2000) . Surprisingly, of the 10 Ptc1 þ /À Gli1 þ /zfd mice obtained in the first generation, six Ptc1 þ /À Gli1 þ /zfd mice developed medulloblastoma by 31 weeks of age (Figure 2a) . The remaining mice showed no signs of medulloblastoma by 53 weeks of age. This increase in tumor incidence was surprising as Gli1 zfd240-394 does not exhibit any DNA-binding activity or transcription activity and it fails to induce cell transformation in culture ( Figure 1A and C). Furthermore, mice expressing Gli1 zfd272-423 under the control of the Wnt1 enhancer do not show any histological abnormalities or activation of Shh target genes in the neural epithelium (Park et al., 2000) . Although Gli1 zfd transcripts are expressed in the mutant mice (Park et al., 2000) , we did not detect any protein product in extracts from the developing cerebellum (Figure 3a) . Therefore, Gli1 zfd is likely a null allele as opposed to a gain-of function mutant. The high incidence of medulloblastoma was reduced to the level reported previously (Goodrich et al., 1997; Wetmore et al., 2000) when we crossed mice from the next three generations. Thus, the initial increase in medulloblastoma incidence likely reflects the segregation of modifier genes present in both C57Bl/6 and 129Sv mice.
We expanded the number of mutant mice in the cohort by crossing Ptc1 þ /À Gli1 þ /zfd mice from the first generation to mice from the first, second and third generations, and we observed all the mice for 12 months (Table 1) . Approximately 24.5% of Ptc1
zfd/zfd mice developed tumors (n ¼ 2/58) and no tumors were identified in Ptc1 (Table 1 ). There is no significant difference in the medulloblastoma incidence of Ptc1
mice (P ¼ 0.8359). These data indicate that the high incidence of medulloblastoma in the first generation 
þ /À mice crossed with Gli1 zfd mutant mice on a mixed C57Bl/6 background (n ¼ 259). The numbers of medulloblastoma in Ptc1
zfd/zfd mice (gray column, n ¼ 2) are shown at each age Figure 3 Expression of Gli1 zfd , Gli2, Ptc1 and N-myc in the developing cerebellum. (a) Western blot analysis showing Gli1 protein levels in the developing cerebellum at postnatal days five (P5 CB). þ / þ and zfd/zfd indicate extracts from the normal cerebellum and the homozygous zinc-finger deletion mutant (zfd) cerebellum, respectively. Extracts (100 mg/lane) from the cerebella or whole cell extracts (20 mg/lane) prepared from 208F cells infected with either MSCV control virus (Control) or MSCV F-Gli1 virus (F-Gli1) were subjected to Western blot analysis. Numbers indicate molecular mass (kDa). (b) Northern analysis showing Gli1 RNA levels in P5 CB. RNA from each sample was subjected to Northern analysis using gene-specific antisense probes for Gli1, Gli2, Ptc1 and N-myc as indicated in the panels. Bracket and asterisks indicate distinct Gli1 transcripts. lZ/lZ indicates extracts from the lacZ knock-in mutant (lZ) cerebellum. Arrowheads indicate the locations of Ethidium Bromide (EtBr) stained 28S and 18S ribosomal RNA (rRNA) used as loading controls Gli1 is important for medulloblastoma formation in Ptc1 þ /À mice H Kimura et al background effect generated by crossing mouse strains with different modifier genes. This compound modifier effect was lost in subsequent generations. Therefore, we conclude that complete loss of Gli1 function significantly reduces medulloblastoma formation in Ptc1 þ /À mice (P-value of medulloblastoma incidence in Ptc1
zfd/zfd mice is 0.0015 and 0.0016, respectively). There was no haploinsufficiency effect of Gli1 on medulloblastoma formation in Ptc1 þ /À mice. We also observed one rhabdomyosarcoma in 53 Ptc1 (Table 1) . However, there was no statistically significant difference among the incidences among the four genotypes. The low incidence of rhabdomyosarcoma in Ptc1
mice on the mixed C57Bl/6, 129Sv and Swiss Webster background makes this result difficult to interpret. The age of onset of medulloblastoma was very similar in Ptc1
mice, occurring between 10 and 41 weeks of age ( Figure 2b ). The majority of the brain tumors (84.6% of the medulloblastoma in Ptc1 þ /À Gli1 þ / þ mice and 84.2% of the medulloblastoma in Ptc1 þ /À Gli1 þ /zfd mice) were observed by 30 weeks of age. Two Ptc1 þ /À Gli1 zfd/zfd mice exhibited medulloblastomas at 24 and 34 weeks of age. These findings indicate that mice with heterozygous loss of Ptc1 developed medulloblastoma by 41 weeks of age and mice lacking functional Gli1 and one copy of Ptc1 did not display a delay in tumor formation. Thus, we conclude that the loss of Gli1 function suppresses medulloblastoma formation in Ptc1 þ /À mice.
Loss of Gli1 does not result in upregulation of Ptc1, Gli2 and N-myc during normal cerebellar development
In the developing cerebellum, Gli1, Gli2, Ptc1, Ptc2 and N-myc are expressed in granule neuron precursor cells (GNPCs) in the external germinal layer (EGL) (Wechsler-Reya and Scott, 1999; Kenney et al., 2003; Lee et al., 2003) . These genes are highly expressed in medulloblastoma and gene expression profiles obtained from mouse medulloblastoma are most similar to the profiles obtained from the developing cerebellum at postnatal day 5 (P5 CB), a structure mostly composed of proliferating GNPCs (Pomeroy et al., 2002; Lee et al., 2003) . Although the incidence of medulloblastoma in
þ /zfd mice was similar (Table 1) , we wanted to exclude the possibility that
Gli1
zfd is a gain-of-function mutant. We performed Western blot analysis to examine the levels of Gli1 expression in P5 CB from Gli1 zfd/zfd mice ( Figure 3a) . A single band of Gli1 protein of approximately 150 kDa was identified in the normal P5 CB. Interestingly, the Gli1 zfd mutant protein was not detectable in P5 CB in Gli1 zfd/zfd mice, indicating that it is either not translated or very unstable in GNPCs. These results support the contention that Gli1 zfd does not act as a dominantnegative mutation during normal development or in tumorigenesis in Ptc1 þ /À mice. Next, we performed Northern analysis to examine Gli1 zfd RNA levels and to determine whether there is any difference in the expression of Gli2 and Ptc1 in P5 CB from the mutant mice. As a control, we used Gli1 lZ/lZ mice (Bai et al., 2002) . These mice display an identical phenotype to Gli1 zfd/zfd mice (Bai et al., 2002) . Gli1 RNA was detectable in P5 CB from both normal and Gli1 zfd/zfd mice but not from Gli1 lZ/lZ mice ( Figure 3b ). Consistent with previous studies, several Gli1 zfd RNA transcripts of different lengths were observed (Figure 3b , asterisks in Gli1 panel). The expression level of Gli2 in P5 CB in the Gli1 mutant mice was similar to that observed in the normal P5 CB. In addition, Ptc1 and N-myc RNAs were present at the similar levels in the P5 CB from normal and Gli1 mutant mice. These data suggest that loss of Gli1 does not affect Gli2, Ptc1 and N-myc expression and that the normal level of Gli2 expression is sufficient to compensate for loss of Gli1 function during cerebellar development.
Gli2 levels are elevated in medulloblastomas from Ptc1
We performed Northern analysis to investigate the expression levels of Shh pathway genes in medulloblastoma arising from Ptc1
Gli1 zfd/zfd mice on a mixed C57Bl/6, 129Sv and Swiss Webster background (Figure 4) . It is technically difficult to completely separate the normal cerebellum from medulloblastoma tissue. Therefore, medulloblastomas were collected together with the entire cerebellum to minimize differences in tissue composition in our studies. RNA was examined by Northern transfer and hybridization using specific probes. Gli1 RNA was detected in both the normal P5 CB and the medulloblastoma samples but not in the adult cerebellum. However, low levels of Gli1 are expressed in Bergmann glial cells as detected by lacZ staining of a knock-in allele (Corrales et al., 2004) and in situ hybridization in this region (Romer et al., 2004) . Only low levels of Gli1 Gli1 is important for medulloblastoma formation in Ptc1 þ /À mice H Kimura et al expression are observed in granule neurons in the adult cerebellum (Romer et al., 2004) . In contrast, we found that Gabra6, which is present in differentiated granule neurons, was present at high levels in the adult but not the P5 CB (Figure 4, Gabra6 panel) . As expected, Gabra6 was detectable in tumors but the levels were much lower than that in the adult cerebellum, indicating that the majority of RNA in medulloblastoma sample is derived from tumor tissue.
Previously, we demonstrated that medulloblastoma from Ptc1 þ /À mice exhibit high levels of Gli1 expression (Wetmore et al., 2000) . Consistent with the previous results, medulloblastomas from Ptc1 þ /À and Ptc1
þ /zfd mice showed high levels of Gli1 expression (Figure 4 ). Gli1 transcripts from the Gli1 zfd mutant allele were also detected in medulloblastoma from Ptc1
zfd/zfd mice but they were present at lower levels compared with those observed in medulloblastomas from Ptc1 þ /À and Ptc1
zfd transcript variants were detected in tumors derived from the Gli1 þ /zfd and Gli1 zfd/zfd mutant mice (Figure 4 , Gli1 panel, lanes 6, 7, 8 and 9). Gli1 transcripts migrating just above 28S rRNA in the Gli1 zfd/zfd tumor sample were expressed at higher levels than in the Gli1 þ /zfd tumor sample (Figure 4 , Gli1 panel, asterisks). The Gli1 transcripts likely reflect splicing variants since the targeted Gli1 locus still contains an intact 5 0 UTR (Park et al., 2000) . Since Gli1 is a target gene of Gli2, this suggests that Gli2 function in Gli1 zfd/zfd tumors may be elevated. Gli2 was detected in all medulloblastomas examined but not in the adult cerebellum although, based on lacZ staining of a knock-in allele, it can be detected in the internal granule layer (IGL) of the cerebellum (Corrales et al., 2004) . Interestingly, the levels of Gli2 were elevated in medulloblastoma from Ptc1 þ /À Gli1 þ /zfd and Ptc1
Gli1 zfd/zfd mice compared to that in medulloblastoma from Ptc1 þ /À mice ( Figure 4 , Gli2 panel, lanes 6, 7, 8 and 9). These data imply that expression of Gli2 is upregulated in medulloblastoma from both Ptc1
þ /zfd and Ptc1 þ /À Gli1 zfd/zfd mice. Thus, Gli2 may contribute to medulloblastoma formation in both Ptc1 þ /À Gli1 þ /zfd and Ptc1 þ /À Gli1 zfd/zfd mice. Previously, we reported that Ptc1 is expressed from the remaining normal allele in mouse medulloblastomas (Wetmore et al., 2000 (Wetmore et al., , 2001 Romer et al., 2004) . Interestingly, the level of Ptc1 detected in medulloblastomas from Ptc1
Gli1 zfd/zfd mice is lower than that detected in P5 CB and adult cerebellum even though these tumors express high levels of Gli1 and Gli2. In contrast, Ptc2 was highly expressed in all medulloblastomas examined and it was detected in P5 CB but not in adult cerebellum. Thus, the level of Ptc1 does not directly correlate with the levels of Gli1 and Gli2 in medulloblastoma in Ptc1 þ /À mice. These data imply that in medulloblastoma, the levels of Ptc1 RNA are regulated independently from the levels of Gli1, Gli2 and Ptc2.
In a subset of human medulloblastoma both Gli1 and N-myc are present at high levels (Pomeroy et al., 2002) . N-myc expression is upregulated by Shh in GNPCs and it promotes proliferation of GNPCs (Kenney et al., 2003; Oliver et al., 2003) . We examined the expression levels of N-myc and c-myc in medulloblastomas arising Figure 4 Expression of the Shh signaling pathway genes and myc family genes in Ptc1 þ /À Gli1 zfd/zfd medulloblastoma. Northern analysis showing expression of Gli1, Gli2, Ptc1, Ptc2, N-myc and c-myc in the normal cerebellum and the cerebellum with medulloblastoma. P5, the developing cerebellum at postnatal day 5 (lane 1); Adult, adult cerebellum over 9 weeks of age (lane 2); 347, 386, 387, cerebellum with medulloblastoma from Ptc1 þ /À mice (lanes 3,4 and 5); 162, 194, cerebellum with medulloblastoma from Ptc1 þ /À Gli1 þ /zfd mice (lanes 6 and 7); 208, 516, the whole cerebellum with medulloblastoma from Ptc1 þ /À Gli1 zfd/zfd mice (lanes 8 and 9). Numbers indicate mouse identification number. RNA from each sample was analysed using gene-specific antisense probes for Gli1, Gli2, Ptc1, Ptc2, N-myc, c-myc and Gabra6 as indicated. Asterisks indicate distinct Gli1 transcripts. CB, cerebellum. EtBr staining indicates ribosomal RNAs (rRNA) of 28S and 18S as loading controls 
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Gli1
zfd/zfd mice exhibited remarkably elevated levels of N-myc expression although Gli1 was absent. C-myc expression was detected in medulloblastomas from Ptc1
þ /À Gli1 þ /zfd and Ptc1 þ /À Gli1 zfd/zfd mice; however, it did not correlate with the levels of Gli1, Gli2 and N-myc. Thus, it is possible that in the absence of Gli1, N-myc contributes more to tumorigenesis than c-myc.
Expression of Gli2 in cells transformed by Gli1
Overexpression of Gli1 dramatically induced expression of Gli1 and Ptc1 in NIH 3T3 cells 48 h after retroviral infection ( Figure 1B) . We performed Northern analysis to examine expression of Gli1, Gli2, Ptc1 and Ptc2 RNAs in NIH 3T3 cells in short-term (48 h after retrovirus infection) and long-term (2 weeks after retrovirus infection) cultures ( Figure 5 ). Since F-Gli1 and NF-Gli1VP16 RNAs were transcribed as the F-Gli1 ires GFP and NF-Gli1VP16 ires GFP RNAs in the viral vector, we were able to distinguish the endogenous and exogenous Gli1 RNAs because of the differences in mRNA size. F-Gli1, NF-Gli1VP16 and F-Gli2 all induced expression of both Gli1 and Ptc1 following short-term expression in NIH 3T3 cells ( Figure 5 , lanes 4, 5 and 7). NF-Gli1VP16 induced higher levels of Gli1 than F-Gli1 ( Figure 5 , lanes 4, 5, 9 and 10). As expected, F-Gli2 was capable of inducing Gli1 and Ptc1, although the levels of Ptc1 observed were lower than those induced by F-Gli1 or NF-Gli1VP16 ( Figure 5 , lanes 4, 5 and 7). In long-term culture of transformed cells, F-Gli1 and NF-Gli1VP16 induced expression of Gli1, Gli2, Ptc1 and Ptc2. In contrast to tumor cells in vivo, in cultured fibroblasts, Ptc1 expression correlated directly with expression of endogenous Gli1 induced in these cells. F-Gli2 was equally efficient at inducing expression of Gli1 in both short-and long-term cultures ( Figure 5 , lanes 7 and 12). Consistent with expression of endogenous Gli1 and Ptc1 proteins in short-term culture ( Figure 1B ), F-Gli2 induced expression of Gli1 and Ptc1 in both short-and long-term cultures ( Figure 5 , lanes 7 and 12). Interestingly, in short-term cultures of NIH 3T3 cells, expression of either F-Gli1 or NFGli1VP16 did not stimulate expression of Gli2 and Ptc2 ( Figure 5, lanes 4 and 5) . These data suggest that Gli1 and Ptc1 are immediate target genes of Gli1 and Gli2 in vitro and they imply that induction of Gli2 and Ptc2 may be regulated indirectly by additional factors during cell transformation. Taken together, these findings suggest that activation of Gli1 is important for tumorigenesis and Gli2 may assist in both cell transformation in vitro and medulloblastoma formation in vivo by Gli1.
Discussion
The Hh signaling pathway plays critical roles in cellular responses during development that are conserved from flies to humans. Deregulation of Hh signaling causes severe developmental abnormalities and can lead to oncogenesis. Heterozygous loss of Ptc1 in mice promotes medulloblastoma formation as a consequence of derepression of Smo (Romer et al., 2004) . Here, we investigated the role of Gli1 in spontaneous medulloblastoma in the Ptc1 þ /À mouse model. In fibroblast cell lines, enforced expression of Gli1 and Gli2 but not Gli3 induced morphological transformation. Thus, both Gli1 and Gli2 are capable of inducing cell transformation. Therefore, we tested whether Gli1 is required for tumor formation in vivo. We found that loss of Gli1 in Ptc1 þ /À mice resulted in a clearly reduced incidence of medulloblastoma. Thus, Gli1 is not only a potential clinical marker in medulloblastoma that have deregulated Shh signaling pathways but also plays a crucial role in medulloblastoma formation. Interestingly, in the few medulloblastomas arising in Ptc1 þ /À Gli1 zfd/zfd mice, the level of Gli2 expression was elevated. Surprisingly, Gli2 
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Gli1 is important for medulloblastoma formation in Ptc1 þ /À mice H Kimura et al expression was also elevated in medulloblastomas from Ptc1 þ /À Gli1 þ /zfd mice. These findings suggest that there is a compensatory mechanism in which reduced Gli1 expression leads to an increase in Gli2 expression. Taken together, our data show that Gli1 is very important in medulloblastoma formation and that Gli2 shares this oncogenic function.
Role of Gli1 and Gli2 in proliferation of GNPCs
Formation of the normal cerebellum requires the precise temporal and spatial regulation of GNPCs proliferation. GNPCs proliferate in the EGL of the cerebellum, exit the cell cycle, differentiate and migrate inward to form the IGL in the postnatal cerebellum. Shh, secreted by cells in the developing Purkinje cell plate, controls the dramatic expansion of the granule cell population during this critical phase of cerebellar development (Dahmane and Ruiz-i-Altaba, 1999; Wallace, 1999; Wechsler-Reya and Scott, 1999) . Mice lacking Shh show severe defects including a reduction in brain size (Chiang et al., 1996) . Furthermore, conditional ablation of Shh in Purkinje cells results in a dramatic reduction of the EGL and the IGL in the developing cerebellum (Lewis et al., 2004) . In addition, the use of small molecule inhibitors of Smo demonstrates that the proliferative activity of GNPCs depends on downstream signaling by Smo (Frank-Kamenetsky et al., 2002; Romer et al., 2004) . Both Gli1 and Gli2 are expressed in the developing EGL (Dahmane and Ruiz-i-Altaba, 1999; Wallace, 1999; Corrales et al., 2004) . However, the cerebellum develops normally in the absence of Gli1 (Park et al., 2000; Bai et al., 2002) . In contrast, loss of Gli2 causes embryonic lethality that can be rescued by a low level of Gli1 expression (Bai and Joyner, 2001 ). Gli2 mutant mice have a reduced EGL and greatly reduced Gli1 expression at birth (Corrales et al., 2004) . Thus, Gli1 and Gli2 have overlapping functions during normal cerebellar development. Here, we found that, in the developing cerebellum, the expression levels of Gli2 and Ptc1 were comparable to those observed in both Gli1 zfd/zfd and Gli1 lZ/lZ mice. These data suggest that Gli2 can maintain expression of Gli1 target genes in the absence of Gli1. This may explain why Gli1 is not essential for proliferation of GNPCs and normal cerebellar development.
Role of Gli1 in medulloblastoma formation in Ptc1
þ /À mice Previously, it was shown that Gli1 induces transformation and promotes tumor formation in allografts of cells expressing E1A (Ruppert et al., 1991) . Gli1 is expressed in approximately a third of human medulloblastoma and it is present at high levels in the spontaneous tumors arising in mice with mutations in Ptc1, DNA ligase IV, cyclin-dependent kinase inhibitors or Parp1 (Lee et al., 2003; Tong et al., 2003) . Therefore, Gli1 is likely to play an important role in medulloblastoma formation. This was underscored by our recent observation that suppression of Smo activity using a small molecule inhibitor reduces Gli1 expression in tumor cells in vivo and eradicates medulloblastoma (Romer et al., 2004) . Here, we demonstrate a remarkable reduction in medulloblastoma incidence in Ptc1 þ /À mice lacking Gli1 function (Table 1) . We also found that medulloblastomas from Ptc1 þ /À mice exhibit high levels of Gli1 but not Gli2 expression compared to the developing cerebellum. Interestingly, the medulloblastoma incidence in Ptc1 þ /À mice was similar to that observed in Ptc1 þ /À Gli11 þ /zfd mice, indicating that there is no haploinsufficiency effect. However, medulloblastoma from Ptc1 þ /À Gli11 þ /zfd mice expressed elevated levels of Gli2 (Figure 4 ). This suggests that increased expression of Gli2 may compensate for the reduced level of Gli1 to regulate target genes responsible for medulloblastoma formation in Ptc1 þ /À mice. In addition, expression of the mutated Gli1 transcripts in Ptc1
zfd/zfd tumors was increased. This also suggests that Gli2 function may be increased as Gli1 is a target gene of Gli2. Thus, there is a threshold of Gli transcriptional activity required for medulloblastoma formation that can be met by contributions from both Gli1 and Gli2.
Gli1 is not absolutely required for medulloblastoma formation as we observed a few tumors in Ptc1 þ /À mice lacking Gli1. This is consistent with a prior report showing that ectopic expression of Shh in cerebellar anlage, using a retroviral vector, induced medulloblastoma in both normal and Gli1 mutant mice (Weiner et al., 2002) . Ptc1 þ /À tumors from mice lacking Gli1 express high levels of Gli2, suggesting that Gli2 may be involved in medulloblastoma formation by deregulating Shh signaling. Medulloblastoma formation can be induced by ectopic expression of Shh in GNPCs in both normal and Gli1 mutant mice (Weiner et al., 2002) . During normal cerebellar development, Shh is made by Purkinje cells from approximately E 17.5 (Lewis et al., 2004) . Thus, autocrine activation of Shh signaling using a Shh retrovirus may promote transformation by deregulating Gli2 expression. In fact, we found that the transforming activities of Gli1 and Gli2 correlated with the levels of transcription activity observed in culture, indicating that cell transformation is mediated by activation of specific target genes. However, Gli1VP16, although a stronger transcription activator than Gli1, was less potent at inducing cell transformation, suggesting that the transcription activation domain confers some specificity for target genes involved in transformation.
Deregulated Shh signaling and N-myc expression in medulloblastoma from Ptc1 þ /À mice Several lines of evidence implicate N-myc regulation of D-type cyclins in the control of GNPC proliferation. Shh induces up regulation of N-myc and increases expression of Cyclin D1 and Cyclin D2 without de novo protein synthesis in GNPCs (Kenney et al., 2003 (Kenney et al., , 2004 Oliver et al., 2003) . Ectopic expression of N-myc induces expression of Cyclin D1 and Cyclin D2 in primary
Gli1 is important for medulloblastoma formation in Ptc1 þ /À mice H Kimura et al GNPCs culture (Ciemerych et al., 2002; Kenney et al., 2004) . Conditional disruption of N-myc in neuronal precursor cells results in severe defects in the cerebellar primordium and the postnatal developing cerebellum (Knoepfler et al., 2002) . Furthermore, mice with loss of both Cyclin D1 and Cyclin D2 exhibit severe cerebellar developmental defects despite the fact that N-myc is still expressed in the EGL (Ciemerych et al., 2002) . Medulloblastomas arising in the various mouse models described above all show high levels of N-myc as well as Gli1 (Lee et al., 2003) . Thus, N-myc may promote medulloblastoma formation as well as proliferation of GNPCs. We found that N-myc was highly expressed in medulloblastomas from Ptc1
zfd/zfd mice as well as in the developing cerebellum. The N-myc level was not directly correlated with the level of Gli1, but it was correlated with Gli2 expression in medulloblastomas. Nmyc levels were higher in tumors from Ptc1 þ /À Gli1 zfd/zfd mice. These results support the contention that Gli2 transcriptional activity is higher in Ptc1
tumors than in the other tumors. These data suggest that N-myc is not a direct target of Gli1 but it may be a direct target of Gli2. Alternatively, it is possible that N-myc expression is regulated by an as yet unidentified effect of Shh, independently of Gli1 and Gli2, in the developing cerebellum and in medulloblastoma formation.
Possible other regulatory signals in the Shh pathway
Previously, it was suggested that wild type Ptc1 mRNA is undetectable in Ptc1 þ /À medulloblastoma (Berman et al., 2002) . However, we routinely observe low levels of transcription from both the normal Ptc1 allele as well as the mutant allele in medulloblastoma from Ptc1 þ /À and Ptc1 þ /À p53 À/À mice (Wetmore et al., 2000 (Wetmore et al., , 2001 Romer et al., 2004) . Here we show the presence of Ptc1, but no up regulation, in medulloblastoma despite the fact that both Gli1 and Gli2 readily induce expression of endogenous Ptc1 in cultured medulloblastoma cells (Romer et al., 2004) . These data suggest that Ptc1 expression may be regulated in both an Shh pathwaydependent and an Shh pathway-independent manner in GNPCs and medulloblastoma. One explanation for these results is that Ptc1 may be controlled by an alternative promoter in the tumor cells. The fact that Ptc1 is not upregulated in medulloblastoma suggests that the negative feedback loop, characteristic of Shh signaling in Drosophila development and mouse embryogenesis (Goodrich and Scott, 1998) , is not functional. Both mouse and human medulloblastomas express high levels of several genes associated with GNPCs proliferation including Cyclin D2, N-myc, CXCR4 and IGF2 as well as Gli1 and Gli2, indicating that the Shh pathway is active (Klein et al., 2001; Pomeroy et al., 2002; Zhao et al., 2002; Lee et al., 2003) . It is possible that the negative feedback loop that modulates physiological Shh signaling is abrogated by an unknown mechanism in tumors and that this contributes to medulloblastoma formation in Ptc1 þ /À mice.
Genetic background effects on tumorigenesis in Ptc1
þ /À mice Previously, we reported that the incidence of medulloblastoma in Ptc1 þ /À mice on a C57Bl/6 background is similar to that on a 129Sv background (Goodrich et al., 1997; Wetmore et al., 2000) . However, Ptc1 þ /À mice on a CD1 background develop more rhabdomyosarcomas than medulloblastomas (Calzada-Wack et al., 2002; Pazzaglia et al., 2002) . Here, the first generation of Ptc1 þ /À Gli1 þ /zfd mice, generated by crossing Ptc1 þ /À mice on a C57Bl/6 background with Gli1 þ /zfd mice derived from 129Sv ES cells but maintained on a Swiss Webster background, exhibited a 60% incidence (six out of 10 mice) of medulloblastoma and a 10% incidence (one out of 10 mice) of rhabdomyosarcoma by 8 months of age. Continued intercrossing of these Ptc1 þ /À Gli1 þ /zfd mice resulted in a reduced incidence (21.8%) of medulloblastoma that was similar to the previously reported incidence (Table 1 ) (Wetmore et al., 2000) . These observations of strain-specific effects on both tumor incidence and spectra in Ptc1 þ /À mice indicate that there may be several modifier genes involved in the generation of medulloblastoma and rhabdomyosarcoma.
Our findings indicate that Gli1 plays an important role in medulloblastoma formation in Ptc1 þ /À mice. We also observed an unanticipated upregulation of Gli2 in the absence of Gli1 during medulloblastoma formation. The ultimate mechanism(s) responsible for controlling target genes in the Shh-Gli1 network and the identity of the genes responsible for tumorigenesis remain to be uncovered. Nevertheless, our study supports the use of Gli1 expression as a molecular target for developing novel therapies to treat the subset of human medulloblastoma associated with increased Shh pathway signaling.
Materials and methods
Plasmids, cell culture, transfections and luciferase assays
For immuno-detection, a FLAG, or an NLS plus FLAG epitope sequence was inserted into the N-terminus of mouse Gli1 and Gli2 (a kind gift from Dr Hiroshi Sasaki from RIKEN, Kobe) in pcDNA3.1. by PCR. A series of Gli1 mutants were constructed by site-directed mutagenesis and restriction enzyme digestion according to the manufacturer's instructions (QuikChange, Stratagene, CA, USA). DNA fragments in all constructs were verified by sequencing.
293T cells, NIH 3T3 cells and 208F cells were maintained in DMEM with 10% FBS and supplements (1 mM Gluta Max (Invitrogen, CA, USA), 100 U/ml penicillin, 100 mg/ml streptomycin). For quantification of the Shh pathway response, a construct containing 8 Â Gli binding sites fused to firefly luciferase reporter (a kind gift from Dr Hiroshi Sasaki) (Sasaki et al., 1999) and a Renilla luciferase reporter (phRL-SV40, Promega) were used. Luciferase activity was measured 48 h after transfection. All luciferase assays were performed according to the manufacturer's instructions (Promega, Dual luciferase assay kit) and were normalized for transfection efficiency using Renilla luciferase activity.
Virus production and retrovirus gene transfer
293T cells were transfected with helper retrovirus plasmids, pPAM3 and pVSV-G, encoding gag-pol-env and the G glycoprotein from vesicular stomatitis virus, respectively, together with the murine stem cell virus (MSCV)-internal ribosome entry site (ires)-green fluorescent protein (GFP) vectors encoding FLAG-tagged, NLS-FLAG-tagged wild type or mutant Gli1 proteins, or pBabe-puro vector encoding FLAG-tagged Gli2 or -Gli3 (The original F-Gli3 clone was a gift from Dr Shunsuke Ishii, RIKEN, Tsukuba (Dai et al., 1999) ). Viruses were harvested 24-60 h post-transfection, pooled and stored on ice. Cells were infected with viruscontaining medium plus Polybrene (10 mg/ml). Infectious units were measured by flow cytometric analysis of GFP expression levels and by counting the number of drug selected NIH 3T3 cell colonies. For focus formation assays, cells were plated at 4 Â 10 5 on 60-mm dishes one day before virus infection, and then they were infected at a multiplicity of infection (MOI) of 0.001 to 10. Culture medium was replaced with DMEM containing 5% FBS and supplements the next day and every 3 days thereafter. For soft agar assays, after virus infection, 2 Â 10 5 cells were suspended in 1 ml of 0.3% noble agar (BD Diagnostic Systems, MD, USA) in IMDM culture medium (Invitrogen, CA, USA) containing 11.25% FBS and supplements. The cell suspension was plated onto 0.6% bottom noble agar in IMDM with 15% FBS and supplements.
Immunoblotting
Western blot analysis was carried using whole-cell lysates as previously described (Kimura and Shiota, 2003) using enhanced chemiluminescence detection (ECL plus, Amersham, NJ or Supersignal West Femto Maximum Sensitivity Substrate, Pierce, IL, USA). Proteins were separated by SDS-PAGE and transferred onto nitrocellulose (Invitrogen, CA, USA) or Immobilon-P membrane (Millipore). Blots were probed with the following antibodies: anti-FLAG (M2 or polyclonal, 1 : 5000, Sigma), anti-C-terminal Gli1 (1 : 2000 or 5000) (Wetmore et al., 2000) , anti-Ptc1 (1 : 1000) (a kind gift from Dr Allen Bale, Yale University, CT, USA).
Animals
Ptc1
þ /À mice obtained from Dr Mathew Scott, (Stanford university, CA, USA) were generated on a mixed C57Bl/6 and 129Sv strain background (Goodrich et al., 1997) and were maintained on a C57Bl/6 background (Wetmore et al., 2000) . Gli1 zfd mice were maintained on a Swiss Webster background (Park et al., 2000) . Gli1 lZ mice were generated from inbred 129SvEv ES cells, backcrossed to Black Swiss strain mice and maintained on a Swiss Webster background. All mice were euthanized when they were moribund, or when they showed signs of increased intracranial pressure, or when extracranial tumors were evident, according to NIH-approved institutional guidelines. In each mouse, the presence of a tumor was confirmed by gross examination of the brain after 12 months of age. If the mouse was not available for examination or if no tumor was detected, the cause of death was indicated as unknown. Genotyping of Ptc1, Gli1 zfd and Gli1 lZ alleles was performed as previously described (Goodrich et al., 1997; Park et al., 2000; Bai et al., 2002) . All the mice were handled in accordance with institutional guidelines and housed in an AAALAC accredited, pathogen free environment on a 12 : 12 h light : dark cycle.
Statistic analysis
Fisher's exact test was used to make comparisons between any two mice groups. P-value o0.01 considered significant.
Northern analysis
RNA extraction from tissues and cell culture was performed using TriPure reagent according to the manufacturer's instructions (Roche Applied Science, Indianapolis, USA). In total, 10 mg of total RNA were separated by electrophoresis under formaldehyde denaturing conditions. RNA was transferred onto a NytranSPC membrane (Schleicher and Schuell BioScience, Inc., NH, USA) and hybridized at 671C with antisense RNA probes for mouse Gli1 (nucleotides corresponding to amino acids 271-837), mouse Gli2 (nucleotides corresponding to amino acids 256-531), mouse Ptc1 (nucleotides corresponding to amino acids 1398-1434 and the 3 0 untranslated region (741 nucleotides) IMAGE clone 3989319), mouse Ptc2 (nucleotides corresponding to amino acids 652-1182 and 3 0 untranslated region (577 nucleotides) IMAGE clone 3972649), mouse N-myc (nucleotides corresponding to amino acids 2-462) and mouse c-myc (nucleotides corresponding to amino acids 2-439), mouse Gabra6 (nucleotides corresponding to amino acids 315-433 and 3 0 untranslated region (521 nucleotides)). IMAGE clones were obtained from Research Genetics, Inc., CA, USA.
